Hashimoto, Tatsuya
Mishima, Hirokazu
Sakai, Chika
Koretaka, Yuichi
Saito, Yoji
Funding for this research was provided by:
Shionogi (N/A)
Article History
Received: 2 November 2021
Accepted: 4 May 2022
First Online: 11 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Tatsuya Hashimoto received honoraria from Daiichi Sankyo, Eisai, Hisamitsu Pharmaceutical, and Pfizer.Hirokazu Mishima and Yuichi Koretaka are employees of Shionogi.Chika Sakai was an employee of Shionogi at the time the study was conducted. Chika Sakai is currently affiliated with Janssen Pharmaceutical K.K., Tokyo, Japan.Yoji Saito received honoraria from Asahi Kasei Pharma, AYUMI Pharmaceutical, Daiichi Sankyo, Edwards Lifesciences, GlaxoSmithKline, Hisamitsu Pharmaceutical, Japan Blood Products Organization, Kyowa Kirin, Maruishi Pharmaceutical, Nihon Kohden, Nippon Zoki Pharmaceutical, Pfizer, Terumo, and Tsumura.